A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
09 2022
Historique:
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: ppublish

Résumé

Following the report of a non-travel-associated cluster of monkeypox cases by the United Kingdom in May 2022, 41 countries across the WHO European Region have reported 21,098 cases and two deaths by 23 August 2022. Nowcasting suggests a plateauing in case notifications. Most cases (97%) are MSM, with atypical rash-illness presentation. Spread is mainly through close contact during sexual activities. Few cases are reported among women and children. Targeted interventions of at-risk groups are needed to stop further transmission.

Identifiants

pubmed: 36082686
doi: 10.2807/1560-7917.ES.2022.27.36.2200620
pmc: PMC9461311
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Euro Surveill. 2018 Sep;23(38):
pubmed: 30255836
N Engl J Med. 2022 Aug 25;387(8):679-691
pubmed: 35866746
Emerg Infect Dis. 2020 Aug;26(8):1826-1830
pubmed: 32338590
Epidemiology. 2019 Sep;30(5):737-745
pubmed: 31205290
J Infect Dis. 2017 Oct 17;216(7):824-828
pubmed: 29029147
BMJ. 2022 Jul 28;378:e072410
pubmed: 35902115
Int J Epidemiol. 1988 Sep;17(3):643-50
pubmed: 2850277
Emerg Infect Dis. 2019 May;25(5):980-983
pubmed: 30848724
Clin Infect Dis. 2005 Dec 15;41(12):1742-51
pubmed: 16288398
MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310
pubmed: 29543790
Euro Surveill. 2022 Jun;27(22):
pubmed: 35656834
Lancet Infect Dis. 2019 Aug;19(8):872-879
pubmed: 31285143
Euro Surveill. 2021 Aug;26(32):
pubmed: 34387184
Br Med Bull. 1998;54(3):693-702
pubmed: 10326294
Emerg Infect Dis. 2020 Apr;26(4):782-785
pubmed: 32023204
J Infect Dis. 1987 Aug;156(2):293-8
pubmed: 3036967
PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141
pubmed: 35148313
N Engl J Med. 2004 Jan 22;350(4):342-50
pubmed: 14736926
Trop Med Infect Dis. 2016 Dec 20;1(1):
pubmed: 30270859

Auteurs

Aisling M Vaughan (AM)

World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.

Orlando Cenciarelli (O)

European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Soledad Colombe (S)

World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Global Outbreak Alert and Response Network (GOARN), Geneva, Switzerland.
Outbreak Research Team, Institute of Tropical Medicine, Antwerp, Belgium.

Luís Alves de Sousa (L)

European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Natalie Fischer (N)

World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Global Outbreak Alert and Response Network (GOARN), Geneva, Switzerland.

Celine M Gossner (CM)

European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Jeff Pires (J)

World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.

Giuditta Scardina (G)

European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Gudrun Aspelund (G)

Centre for Health Security and Communicable Disease Control, The Directorate of Health, Reykjavik, Iceland.

Margarita Avercenko (M)

Infectious Disease Prevention and Control Unit, Department of Infectious Risks Analysis and Prevention, Centre for Disease Prevention and Control of Latvia, Riga, Latvia.

Sara Bengtsson (S)

Unit for Diagnostics Preparedness of Notifiable and High Consequence Pathogens, Public Health Agency of Sweden, Solna, Sweden.

Paula Blomquist (P)

Field Services, United Kingdom Health Security Agency, London, United Kingdom.

Anna Caraglia (A)

Directorate General of Health Prevention, Ministry of Health, Rome, Italy.

Emilie Chazelle (E)

Santé publique France, the French National Public Health Agency, Saint-Maurice, France.

Orna Cohen (O)

Division of Epidemiology, Public Health Services, Ministry of Health, Jerusalem, Israel.

Asuncion Diaz (A)

National Centre of Epidemiology, Carlos III Health Institute, CIBER in Infectious Diseases (CIBERINFEC), Madrid, Spain.

Christina Dillon (C)

Health Services Executive, Health Protection Surveillance Centre, Dublin, Ireland.

Irina Dontsenko (I)

Department of Communicable Diseases, Health Board, Tallinn, Estonia.

Katja Kotkavaara (K)

Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.

Mario Fafangel (M)

Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.

Federica Ferraro (F)

Directorate General of Health Prevention, Ministry of Health, Rome, Italy.

Richard Firth (R)

Public Health Wales, Cardiff, United Kingdom.

Jannik Fonager (J)

Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Christina Frank (C)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Mireia G Carrasco (MG)

Ministry of Health, Government of Andorra, Andorra la Vella, Andorra.

Kassiani Gkolfinopoulou (K)

Surveillance Coordination Department. Hellenic National Public Health Organization (EODY), Athens, Greece.

Marte Petrikke Grenersen (MP)

The Norwegian Institute of Public Health, Oslo, Norway.

Bernardo R Guzmán Herrador (BR)

Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.

Judit Henczkó (J)

Department of Microbiological Reference Laboratory, National Public Health Center, Budapest, Hungary.

Elske Hoornenborg (E)

Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, the Netherlands.

Derval Igoe (D)

Health Services Executive, Health Protection Surveillance Centre, Dublin, Ireland.

Maja Ilić (M)

Croatian Institute of Public Health, Zagreb, Croatia.

Klaus Jansen (K)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Denisa-Georgiana Janță (DG)

National Centre of Surveillance and Control of Communicable Disease, National Institute of Public Health Romania, Bucharest, Romania.

Tone Bjordal Johansen (TB)

The Norwegian Institute of Public Health, Oslo, Norway.

Ana Kasradze (A)

Head of Public Health Emergency Preparedness and Response Division, National Center for Disease Control and Public Health, Tbilisi, Georgia.

Anders Koch (A)

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Jan Kyncl (J)

Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.

João Vieira Martins (JV)

Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.

Andrew McAuley (A)

Public Health Scotland, Edinburgh, Scotland, United Kingdom.

Kassiani Mellou (K)

Directorate of Epidemiological Surveillance and Intervention for Infectious Diseases, Hellenic National Public Health Organization (EODY), Athens, Greece.

Zsuzsanna Molnár (Z)

Department of Communicable Disease Epidemiology and Infection Control, National Public Health Center, Budapest, Hungary.

Zohar Mor (Z)

Public Health Services, Ministry of Health, Jerusalem, Israel.
School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel.

Joël Mossong (J)

Health Directorate, Luxembourg, Luxembourg.

Alina Novacek (A)

Austrian Agency for Health and Food Safety (AGES), Vienna, Austria.

Hana Orlikova (H)

Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.

Iva Pem Novosel (I)

Croatian Institute of Public Health, Zagreb, Croatia.

Maria K Rossi (MK)

Public Health Scotland, Edinburgh, Scotland, United Kingdom.

Malgorzata Sadkowska-Todys (M)

National Institute of Public Health (NIH) - National Research Institute, Warsaw, Poland.

Clare Sawyer (C)

Communicable Disease Surveillance Centre, Public Health Wales, Cardiff, United Kingdom.

Daniela Schmid (D)

Austrian Agency for Health and Food Safety (AGES), Vienna, Austria.

Anca Sîrbu (A)

National Centre of Surveillance and Control of Communicable Disease, National Institute of Public Health Romania, Bucharest, Romania.

Klara Sondén (K)

Unit for Diagnostics Preparedness of Notifiable and High Consequence Pathogens, Public Health Agency of Sweden, Solna, Sweden.

Arnaud Tarantola (A)

Santé publique France Regional Office, Saint-Denis, Île-de-France, France.

Margarida Tavares (M)

Emerging Infectious Diseases Unit, Department of Infectious Diseases, Centro Hospitalar Universitário de São João, Porto, Portugal.
Laboratory for Integrative and Translational Research in Population Health (ITR), and EPIUnit - Institute of Public Health, University of Porto, Porto, Portugal.
National Program for Sexually Transmitted Infections and HIV Infection, Directorate-General of Health, Lisbon, Portugal.

Marianna Thordardottir (M)

Centre for Health Security and Communicable Disease Control, The Directorate of Health, Reykjavik, Iceland.

Veronika Učakar (V)

Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.

Catharina Van Ewijk (C)

National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Juta Varjas (J)

Department of Communicable Diseases, Health Board, Tallinn, Estonia.

Anne Vergison (A)

Health Directorate, Luxembourg, Luxembourg.

Roberto Vivancos (R)

Field Services, United Kingdom Health Security Agency, London, United Kingdom.

Karolina Zakrzewska (K)

National Institute of Public Health (NIH) - National Research Institute, Warsaw, Poland.

Richard Pebody (R)

World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.

Joana M Haussig (JM)

European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH